Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis
What this study shows
Deleting Tsc1 from cultured mouse hippocampal neurons raised phospho-S6 and made the network fire more than twice as much as controls by day 14, in an epilepsy-like bursting pattern; four days of rapamycin brought activity back to control levels. Many gene-expression and synaptic changes in the knockout cultures, such as high Arc and fewer surface AMPA receptors, turned out to be secondary responses to the high activity, not direct effects of mTOR. In hippocampal CA1, Tsc1 loss in single pyramidal neurons weakened the inhibitory synaptic input they received and raised their excitation/inhibition ratio, while their intrinsic excitability was lower, not higher. Forebrain Tsc1 knockout mice had more severe kainate-induced seizures (80% died, while all controls survived), and seven days of rapamycin in vivo restored inhibition and normalised the E/I ratio. Boundary: mouse neurons, cultures and brain slices; Tsc1 deleted in excitatory neurons only; seizure test used a chemical convulsant.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Tsc1 floxed mice: lentiviral Cre in dissociated hippocampal cultures (multi-electrode arrays, microarrays); CaMKIIa-Cre forebrain cKO (kainate seizures); sparse or widespread AAV-Cre in CA1 with slice electrophysiology; rapamycin in vitro and in vivo) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Tsc1 floxed mice: lentiviral Cre in dissociated hippocampal cultures (multi-electrode arrays, microarrays); CaMKIIa-Cre forebrain cKO (kainate seizures); sparse or widespread AAV-Cre in CA1 with slice electrophysiology; rapamycin in vitro and in vivo |
| Journal | Neuron |
| Year | 2013 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1016/j.neuron.2013.03.017 · PMID 23664616 · Free full text (PMC3690324) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Tsc1 deletion (lentiviral/AAV Cre, CaMKIIa-Cre); rapamycin |
| Target | TSC1/TSC2 -> mTORC1 |
| Model | Mouse |
| Effect | Tsc1 loss weakened inhibitory synapses, raised E/I ratio and network excitability; rapamycin reversed it |
In the Atlas
Related topics
Links in the pathway map
- Supports TSC1/TSC2 inhibits mTORC1
- Supports Rapamycin inhibits mTORC1
More studies on this topic
- Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis (2008)
- A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells (2002)
- mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis (2026)
- Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy (2017)
Thank you. Your answer was counted anonymously.